CVIR Endovascular (Dec 2022)

Endovascular treatment of haemorrhagic pancreatic serous cystadenoma

  • Thomas Le Tat,
  • Robert Carlier,
  • Mostafa El Hajjam,
  • Guillaume-Marie Sarrot,
  • Ilan Obadia,
  • Mickael Tordjman,
  • Jeffery Zhou

DOI
https://doi.org/10.1186/s42155-022-00343-w
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Background Pancreatic microcystic serous cystadenoma are rare benign pancreatic tumors. No treatment is needed in most cases as this lesion is often discovered incidentally. Surgery is not required except in symptomatic cases. Case presentation We report herein a rare case of pancreatic serous cystadenoma complicated with a hemorrhage in a 95 years old patient treated with arterial embolization since surgery was not possible. The patient recovered without any adverse events or bleed recurrence in the 6 months following the procedure. Conclusion Hemorrhage secondary to a pancreatic serous cystadenoma was successfully treated with arterial embolization, which may represent an alternative therapeutic option to surgery.